Semaglutide or Tirzepatide + Tesamorelin Users without access to Retatrutide might consider stacking Tesamorelin with available GLP-1 medications
Scientific research on NAFLD & IV glutathione showed remarkable results: ALT Reduction : Liver inflammation markers decreased significantly (p=0.014) Fat Reduction : Controlled attenuation parameter (CAP) values improved in responders Metabolic Benefits : Triglycerides, non-esterified fatty acids, and ferritin levels all decreased These results were achieved with just 300mg daily oral glutathione
Water, stevia, glycerine, xanthan gum, potassium sorbate, potassium benzoate, natural strawberry and kiwi flavor, citric acid
The same methods were used to assess the status of the induced gastric lesions
Clinical trials show that GLP-1 medications like semaglutide and tirzepatide can lead to a 1520% weight reduction over 1216 months, while diet and exercise typically result in 510% weight loss in the first year
Discuss timing of all medications with your healthcare provider